
Gemtesa: Uses, Dosage, Side Effects, Warnings - Drugs.com
Sep 10, 2025 · Gemtesa (vibegron) is used to treat overactive bladder symptoms (OAB) in adults or men taking medicine for benign prostatic hyperplasia (BPH). Includes Gemtesa side effects, …
Gemtesa (vibegron) : Uses, Side Effects, Interactions, Pictures ... - WebMD
Mar 13, 2024 · Find patient medical information for Gemtesa (vibegron) on WebMD including its uses, side effects and safety, interactions, pictures, warnings, and user ratings
Gemtesa: Uses, Side Effects, Dosage, Price, and More
Sep 17, 2025 · Gemtesa is a prescription medication for adults with overactive bladder. It may help reduce symptoms like frequent urination and urge incontinence. Gemtesa is generally …
Vibegron (oral route) - Side effects & dosage - Mayo Clinic
Dec 1, 2025 · Drug Interactions Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. …
GEMTESA® (vibegron) 75 mg tablets
Find information about GEMTESA® (vibegron), a treatment option for your symptoms.
Gemtesa (Vibegron Tablets): Side Effects, Uses, Dosage ... - RxList
Apr 24, 2025 · Gemtesa (Vibegron Tablets) may treat, side effects, dosage, drug interactions, warnings, patient labeling, reviews, and related medications including drug comparison and …
GEMTESA (Sumitomo Pharma America, Inc.): FDA Package Insert
Apr 1, 2025 · Sumitomo Pharma America, Inc.: GEMTESA is a beta-3 adrenergic agonist indicated for the treatment of: overactive bladder (OAB) with symptoms of urge urinary …
Gemtesa (vibegron) for Overactive Bladder: Drug Warnings
Gemtesa (vibegron) is a prescription medication used to treat an overactive bladder. Gemtesa may cause serious side effects, including the inability to empty your bladder (urinary retention). …
Vibegron: Uses, Dosage, Side Effects, Warnings - Drugs.com
Jan 21, 2025 · Vibegron is used for overactive bladder (OAB) and symptoms in men with benign prostatic hyperplasia (BPH). It is a once-daily tablet that is sold under the brand name …
Monitor patients for signs and symptoms of urinary retention, particularly in patients with bladder outlet obstruction and patients taking muscarinic antagonist medications for the treatment of …